Post-hoc analyses of lebrikizumab trial (MILLY): enhanced efficacy in patients with T2-high and eosinophilic asthmaJ. Corren, W. Soong, R. Zitnik,R. Gopalan,L. Sun,N. A. HananiaALLERGY(2021)引用 0|浏览2暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要